ZTEK zentek.com: שווי חברה להכנסות

A stable Canadian base and the absence of sanction risks provide Zentek Ltd. (ZTEK) with a reliable operational backdrop. The enterprise value-to-revenue multiple clearly demonstrates the valuation trend, with the parameter stabilizing at 649500.00. Leadership in the development of antibacterial nanofilters complements a closed patent strategy, where graphene coatings ensure high B2B customer loyalty.
ZTEK (Zentek Corp): פילוחים אנליטיים ודוחות לפי אינדיקטורים

Zentek Ltd. is scaling the commercialization of graphene nanomaterials for medicine and ecology while remaining in a stage of active technological growth. This enterprise value-to-revenue (EV/Revenue) valuation compares the total value of the business with sales volume, excluding the impact of leverage, which allows investors to assess the efficiency of patent monetization and the sustainability of capitalization in an environment of expensive debt capital.